Valbenazine
VIDEO: Emerging therapies in tardive dyskinesia
Andres Deik, MD, assistant professor of clinical neurology and associate director of the Movement Disorders Fellowship Program at the University of Pennsylvania, discussed the importance of early recognition, screening patients for tardive dyskinesia symptoms at the first follow-up visit after prescribing the antipsychotic and using a multidisciplinary approach to optimize care coordination for patients with, or at risk for, TD.
VIDEO: Lessening the high health care burden of TD
Andres Deik, MD, assistant professor of clinical neurology and associate director of the Movement Disorders Fellowship Program at the University of Pennsylvania, discussed the importance of early recognition, screening patients for tardive dyskinesia symptoms at the first follow-up visit after prescribing the antipsychotic and using a multidisciplinary approach to optimize care coordination for patients with, or at risk for, TD.
VIDEO: Optimizing care coordination with a multidisciplinary approach for patients with TD
Andres Deik, MD, assistant professor of clinical neurology and associate director of the Movement Disorders Fellowship Program at the University of Pennsylvania, discussed the importance of early recognition, screening patients for tardive dyskinesia symptoms at the first follow-up visit after prescribing the antipsychotic and using a multidisciplinary approach to optimize care coordination for patients with, or at risk for, TD.
VIDEO: Current clinical recommendations advised for TD
Andres Deik, MD, assistant professor of clinical neurology and associate director of the Movement Disorders Fellowship Program at the University of Pennsylvania, discussed the importance of early recognition, screening patients for tardive dyskinesia symptoms at the first follow-up visit after prescribing the antipsychotic and using a multidisciplinary approach to optimize care coordination for patients with, or at risk for, TD.
VIDEO: Likeliness of atypical antipsychotics causing TD
Andres Deik, MD, assistant professor of clinical neurology and associate director of the Movement Disorders Fellowship Program at the University of Pennsylvania, discussed the importance of early recognition, screening patients for tardive dyskinesia symptoms at the first follow-up visit after prescribing the antipsychotic and using a multidisciplinary approach to optimize care coordination for patients with, or at risk for, TD.